Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Zomedica Corp.

Get SEC filing alerts via email and in your feed for Zomedica Corp.

ZOM ZOMDF

Zomedica Corp.

About Zomedica Corp.

Zomedica Corp. is an animal health company developing and marketing diagnostic and therapeutic products for companion animals and horses. Its portfolio includes innovative diagnostics, digital microscopy, remote monitoring, and pain/inflammation treatment devices. Serving veterinarians and pet owners globally, Zomedica focuses on improving animal care, practice efficiency, and profitability through proprietary technologies, strategic acquisitions, and a diversified product pipeline.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Zomedica Corp.

1
1
Zomedica Corp. Zomedica Reports 35% Revenue Growth to $8.8 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Zomedica Corp. Zomedica Reports $32M Revenue Growth and Widened Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Zomedica Corp. Zomedica Reports 16% Revenue Growth to $8.1 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Zomedica Corp. Zomedica Reports 14% Revenue Growth in Q2 2025 Despite Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Zomedica Corp. Zomedica Reports $27.3 Million Revenue for Fiscal Year 2024, Net Loss Increases to $46.9 Million

Via official filing (AI summary) | about 1 year ago | 0 comments